BD Medical, a segment of Becton, Dickinson and Company BDX, commonly known as BD, recently released new clinical data demonstrating that its infusion set with BD FlowSmart technology may improve ...
BD Medical, a segment of Becton, Dickinson and Company BDX, recently announced that it has received FDA 510(k) clearance for a new insulin infusion set with BD FlowSmart technology. Notably, it is the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel extended-wear insulin infusion set was usable ...
The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...
Medtronic MiniMed Paradigm Insulin Infusion Sets have been recalled, according to an FDA Med Watch report. The recall is due to a malfunction affecting products manufactured from October 2001 through ...
Medtronic plc MDT recently launched an easy-to-use insulin infusion set, MiniMed Mio Advance, for the insulin-dependent diabetic patients in the United States. The launch expands Medtronic’s existing ...
Medtronic is recalling specific lots of MiniMed infusion sets after learning of the risk of insulin overdelivery. The global, voluntary recall affects older insulin pump infusion sets that featured a ...
Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set DUBLIN, Nov. 15, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global ...
Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results